1
|
Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.
|
Clin Cancer Res
|
2008
|
1.90
|
2
|
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study.
|
Haematologica
|
2010
|
1.16
|
3
|
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study.
|
Am J Hematol
|
2014
|
1.13
|
4
|
Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.
|
Int J Hematol
|
2010
|
0.96
|
5
|
Radiologic features of all-trans-retinoic acid syndrome.
|
AJR Am J Roentgenol
|
2002
|
0.94
|
6
|
Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
|
Korean J Intern Med
|
2002
|
0.83
|
7
|
Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings.
|
Korean J Radiol
|
2004
|
0.83
|
8
|
The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.
|
Biol Blood Marrow Transplant
|
2010
|
0.82
|
9
|
Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas.
|
Pathology
|
2009
|
0.80
|
10
|
Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.
|
J Korean Med Sci
|
2011
|
0.77
|
11
|
Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience.
|
Clin Nephrol
|
2012
|
0.75
|
12
|
Role of type II NKT cells in the suppression of graft-versus-host disease.
|
Crit Rev Immunol
|
2008
|
0.75
|
13
|
Analysis of NOTCH1 extracellular juxtamembrane expansion mutations in acute leukemias and multiple myelomas.
|
APMIS
|
2009
|
0.75
|
14
|
Absence of JAK1 exon 10 and 13 mutations in acute leukemias and multiple myelomas.
|
Eur J Haematol
|
2008
|
0.75
|
15
|
Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
|
Int J Hematol
|
2002
|
0.75
|